Caribou Biosciences (CRBU) EBIAT (2020 - 2025)
Historic EBIAT for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to -$27.5 million.
- Caribou Biosciences' EBIAT rose 2057.43% to -$27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.1 million, marking a year-over-year decrease of 608.7%. This contributed to the annual value of -$149.1 million for FY2024, which is 4608.11% down from last year.
- Caribou Biosciences' EBIAT amounted to -$27.5 million in Q3 2025, which was up 2057.43% from -$54.1 million recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' EBIAT ranged from a high of -$10.0 million in Q3 2023 and a low of -$54.1 million during Q2 2025
- Over the past 5 years, Caribou Biosciences' median EBIAT value was -$27.5 million (recorded in 2025), while the average stood at -$28.4 million.
- As far as peak fluctuations go, Caribou Biosciences' EBIAT crashed by 66447.65% in 2021, and later skyrocketed by 6246.48% in 2023.
- Caribou Biosciences' EBIAT (Quarter) stood at -$18.5 million in 2021, then plummeted by 46.05% to -$27.0 million in 2022, then dropped by 27.85% to -$34.5 million in 2023, then dropped by 2.85% to -$35.5 million in 2024, then rose by 22.38% to -$27.5 million in 2025.
- Its EBIAT stands at -$27.5 million for Q3 2025, versus -$54.1 million for Q2 2025 and -$40.0 million for Q1 2025.